Form 4: American Healthcare REIT EVP Sells 1,500 Shares

Mark E. Foster, EVP, GC & Secretary of American Healthcare REIT, Inc., sold 1,500 shares of common stock for approximately $49.35 per share under a Rule 10b5-1 plan.

Summary

• Mark E. Foster, Executive Vice President, General Counsel, and Secretary of American Healthcare REIT, Inc. (AHR), reported a sale of common stock.
• The transaction involved the disposition of 1,500 shares of American Healthcare REIT, Inc. Common Stock.
• The sale occurred on November 11, 2025, at a weighted average price of $49.3531 per share.
• The shares were sold in multiple trades with prices ranging from $49.3500 to $49.3700.
• Following this transaction, Mark E. Foster directly beneficially owns 57,600 shares of Common Stock.
• The transaction was executed pursuant to a Rule 10b5-1(c) pre-arranged trading plan.

Sentiment

Score: 5

Explanation: Neutral. While an insider sale can be seen as slightly negative, the execution under a Rule 10b5-1 plan mitigates concerns about its signaling effect, suggesting it's a pre-planned liquidity event rather than a reaction to new negative information.

Positives

• The transaction was conducted under a Rule 10b5-1 plan, indicating a pre-scheduled sale rather than a discretionary one based on new material non-public information.

Negatives

• An insider sale, even if pre-planned, can sometimes be perceived negatively by the market as it reduces the insider's direct equity stake in the company.

Risks

• No specific risks were mentioned in this Form 4 filing beyond the inherent market perception of insider sales.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Management Comments

• Mark E. Foster undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the reported range.

Industry Context

This is a routine insider transaction filing and does not provide specific insights into broader industry trends or competitive landscape. It reflects an individual executive's pre-planned stock disposition within the healthcare REIT sector.

Comparison to Industry Standards

• Insider transactions, particularly those executed under Rule 10b5-1 plans, are common across all industries, including the REIT sector. The sale of 1,500 shares by an executive holding 57,600 shares is a relatively small percentage of their total holdings, which is not uncommon for diversification or liquidity purposes.

Stakeholder Impact

• Shareholders: May observe a slight decrease in insider ownership, but the Rule 10b5-1 plan context suggests no immediate negative implications for company fundamentals.
• Employees: No direct impact indicated by this filing.
• Customers: No direct impact indicated by this filing.
• Suppliers: No direct impact indicated by this filing.
• Creditors: No direct impact indicated by this filing.

Next Steps

• No specific future actions or milestones are mentioned in this filing beyond the reporting person's undertaking to provide detailed trade information upon request.

Key Dates

Recommendation

The filing reports a routine insider stock sale executed under a pre-arranged Rule 10b5-1 plan. This type of transaction is generally not indicative of a change in company fundamentals or future prospects. While it reduces insider ownership, the pre-planned nature suggests it's for personal financial management rather than a reaction to new information. Therefore, it does not warrant a change in investment recommendation based solely on this filing.

Keywords

American Healthcare REIT, AHR, Insider Trading, Form 4, Stock Sale, Executive Compensation, Rule 10b5-1, Mark E. Foster